INNOVUS PHARMACEUTICALS, INC. Restricted Stock or Unit Expense
INNOVUS PHARMACEUTICALS, INC. reported Restricted Stock or Unit Expense of $120.98 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2015-11-16
- INNOVUS PHARMACEUTICALS, INC. restricted stock or unit expense for the quarter ending 2015-09-30 was $120.98K, a 83.85% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. restricted stock or unit expense for the quarter ending 2015-06-30 was $120.98K, a 83.85% decline year-over-year.
- INNOVUS PHARMACEUTICALS, INC. restricted stock or unit expense for the quarter ending 2014-09-30 was $749.00K.
- INNOVUS PHARMACEUTICALS, INC. restricted stock or unit expense for the quarter ending 2014-06-30 was $749.00K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month |
|---|---|---|
| 2015-09-30 | $120.98K 10-Q · filed 2015-11-16 | $241.97K derived: sum of 2 quarters · filed 2015-11-16 |
| 2015-06-30 | $120.98K 10-Q · filed 2015-08-14 | |
| 2014-09-30 | $749.00K 10-Q · filed 2015-11-16 | $1.50M derived: sum of 2 quarters · filed 2015-11-16 |
| 2014-06-30 | $749.00K 10-Q · filed 2015-08-14 |